UPDATE: Intersect ENT (XENT) Posts Q2 Loss of $2.36/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts XENT Hot Sheet
Join SI Premium – FREE
(Updated - September 3, 2014 4:41 PM EDT)
Intersect ENT (Nasdaq: XENT) reported Q2 EPS of ($2.36), versus analyst estimate of ($2.59). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $8.46 million.
For earnings history and earnings-related data on (XENT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Black Hills Corp. (BKH) Tops Q3 EPS by 6c, Misses on Revenue; Offers FY26 EPS Guidance
- Mueller Water Products, Inc. (MWA) Reports In-Line Q4 EPS; Offers Guidance
- Miller Industries (MLR) Misses Q3 EPS by 11c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
